Legislature(2015 - 2016)
2016-04-13 House Journal
Full Journal pdf2016-04-13 House Journal Page 2299 SB 142 The following was read the second time: CS FOR SENATE BILL NO. 142(L&C) am "An Act relating to insurance coverage for anti-cancer medications." with the: Journal Page L&C RPT HCS(L&C) NT 4DP 2222 FN1: ZERO(CED) 2223 Representative Millett moved and asked unanimous consent that the following committee substitute be adopted in lieu of the original bill: HOUSE CS FOR CS FOR SENATE BILL NO. 142(L&C) "An Act relating to insurance coverage for anti-cancer medications; and providing for an effective date." (technical title change) There being no objection, it was so ordered. Representative Millett moved and asked unanimous consent that HCS CSSB 142(L&C) be considered engrossed, advanced to third reading, and placed on final passage. There being no objection, it was so ordered. HCS CSSB 142(L&C) was read the third time. The question being: "Shall HCS CSSB 142(L&C) pass the House?" The roll was taken with the following result: 2016-04-13 House Journal Page 2300 HCS CSSB 142(L&C) Third Reading Final Passage YEAS: 36 NAYS: 1 EXCUSED: 1 ABSENT: 2 Yeas: Chenault, Claman, Drummond, Edgmon, Foster, Gara, Gattis, Guttenberg, Herron, Johnson, Josephson, Kawasaki, Keller, Kito, Kreiss-Tomkins, LeDoux, Lynn, Millett, Munoz, Nageak, Neuman, Olson, Ortiz, Pruitt, Reinbold, Saddler, Seaton, Spohnholz, Stutes, Talerico, Tarr, Thompson, Tilton, Tuck, Vazquez, Wool Nays: Wilson Excused: Hawker Absent: Colver, Hughes And so, HCS CSSB 142(L&C) passed the House. Representative Millett moved and asked unanimous consent that the roll call on the passage of the bill be considered the roll call on the effective date clause. There being no objection, it was so ordered. HCS CSSB 142(L&C) was referred to the Chief Clerk for engrossment.